Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Triferic Avnu Generic Name & Formulations
Legal Class
Rx
General Description
Elemental iron (III) (as ferric pyrophosphate citrate) 1.5mg/mL; soln for IV infusion.
Pharmacological Class
Hematinic.
See Also
How Supplied
Ampules (5mL)—5, 40; (50mL)—4, 24; Single-dose ampules (4.5mL)—10, 40; Packets— 1, 100
Manufacturer
Generic Availability
NO
Triferic Avnu Indications
Indications
Iron replacement to maintain hemoglobin in adults with hemodialysis-dependent chronic kidney disease (HDD-CKD).
Limitations of Use
Not for use in patients receiving peritoneal dialysis. Not studied in patients receiving home hemodialysis.
Triferic Avnu Dosage and Administration
Adult
Administer as a slow continuous IV infusion over 3–4hrs via pre- or post-dialyzer infusion line, or a separate connection to the venous blood line. Give 6.75mg (undiluted) at each dialysis procedure.
Children
Not established.
Triferic Avnu Contraindications
Not Applicable
Triferic Avnu Boxed Warnings
Not Applicable
Triferic Avnu Warnings/Precautions
Warnings/Precautions
Monitor for hypersensitivity reactions during and after hemodialysis until clinically stable. Have personnel and resuscitative equipment immediately available. Determine iron status on pre-dialysis blood samples. Pregnancy. Advise females of reproductive potential to use effective contraception during and for at least 2weeks after therapy completion. Nursing mothers.
Triferic Avnu Pharmacokinetics
See Literature
Triferic Avnu Interactions
Not Applicable
Triferic Avnu Adverse Reactions
Adverse Reactions
Headache, peripheral edema, asthenia, AV fistula thrombosis, urinary tract infection, AV fistula site hemorrhage, pyrexia, fatigue, procedural hypotension, muscle spasms, pain in extremity, back pain, dyspnea.
Triferic Avnu Clinical Trials
See Literature
Triferic Avnu Note
Not Applicable
Triferic Avnu Patient Counseling
See Literature
Images
